Literature DB >> 22777291

Lysophospholipid acyltransferases: 1-acylglycerol-3-phosphate O-acyltransferases. From discovery to disease.

Anil K Agarwal1.   

Abstract

PURPOSE OF REVIEW: Over the past several years, many more isoforms for the same enzymes, specifically for 1-acylglycerol-3-phosphate O-acyltransferases (AGPATs), have been cloned and studied. In this review, we summarize their biochemical features and discuss their functional role. RECENT
FINDINGS: The most significant role of these AGPATs appeared from our observation of AGPAT2 in the biology of adipose tissue (adipocytes) in humans and mice. Other isoforms are shown to be implicated in lung, reproductive and cardiac muscle function and in the cause of cancer. In-vitro substrate specificities of these AGPATs also suggest the in-vivo role of these AGPATs in remodeling of several of the glycerophospholipids.
SUMMARY: Despite significant progress in understanding the role of these AGPATs, much is still to be discovered in terms of how each of these AGPATs function in the presence or absence of other AGPATs and what their functional role might be.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22777291     DOI: 10.1097/MOL.0b013e328354fcf4

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  22 in total

1.  A two-helix motif positions the lysophosphatidic acid acyltransferase active site for catalysis within the membrane bilayer.

Authors:  Rosanna M Robertson; Jiangwei Yao; Stefan Gajewski; Gyanendra Kumar; Erik W Martin; Charles O Rock; Stephen W White
Journal:  Nat Struct Mol Biol       Date:  2017-07-17       Impact factor: 15.369

Review 2.  What the genetics of lipodystrophy can teach us about insulin resistance and diabetes.

Authors:  Camille Vatier; Guillaume Bidault; Nolwenn Briand; Anne-Claire Guénantin; Laurence Teyssières; Olivier Lascols; Jacqueline Capeau; Corinne Vigouroux
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

Review 3.  Cellular fatty acid metabolism and cancer.

Authors:  Erin Currie; Almut Schulze; Rudolf Zechner; Tobias C Walther; Robert V Farese
Journal:  Cell Metab       Date:  2013-06-20       Impact factor: 27.287

4.  Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-/- lipodystrophic mice independent of hepatocyte leptin receptors.

Authors:  Víctor A Cortés; Kelly M Cautivo; Shunxing Rong; Abhimanyu Garg; Jay D Horton; Anil K Agarwal
Journal:  J Lipid Res       Date:  2013-11-30       Impact factor: 5.922

5.  Hepatic gluconeogenesis is enhanced by phosphatidic acid which remains uninhibited by insulin in lipodystrophic Agpat2-/- mice.

Authors:  Shireesha Sankella; Abhimanyu Garg; Jay D Horton; Anil K Agarwal
Journal:  J Biol Chem       Date:  2014-01-14       Impact factor: 5.157

6.  Off-Target V(D)J Recombination Drives Lymphomagenesis and Is Escalated by Loss of the Rag2 C Terminus.

Authors:  Martina Mijušković; Yi-Fan Chou; Vered Gigi; Cory R Lindsay; Olga Shestova; Susanna M Lewis; David B Roth
Journal:  Cell Rep       Date:  2015-09-10       Impact factor: 9.423

7.  Phosphatidic acid: a new therapeutic lead to suppress hepatic glucose production.

Authors:  Anil K Agarwal; Shireesha Sankella
Journal:  Diabetes Manag (Lond)       Date:  2014

Review 8.  Congenital generalized lipodystrophies--new insights into metabolic dysfunction.

Authors:  Nivedita Patni; Abhimanyu Garg
Journal:  Nat Rev Endocrinol       Date:  2015-08-04       Impact factor: 43.330

9.  Metabolic, Reproductive, and Neurologic Abnormalities in Agpat1-Null Mice.

Authors:  Anil K Agarwal; Katie Tunison; Jasbir S Dalal; Sneha S Nagamma; F Kent Hamra; Shireesha Sankella; Xinli Shao; Richard J Auchus; Abhimanyu Garg
Journal:  Endocrinology       Date:  2017-11-01       Impact factor: 4.736

Review 10.  Disorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genes.

Authors:  Ya-Wen Lu; Steven M Claypool
Journal:  Front Genet       Date:  2015-02-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.